Oncostem Diagnostics Private Limited, a active private limited company, was established on 15 March 2011 in Bangalore, Karnataka, India. Engaging in oncology clinics & cancer treatment within the professional, scientific and technical sector, it holds CIN: U85110KA2011PTC057624. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 17 professional, Its leadership includes Manjiri Manohar Bakre (Director), Thallam Satyanarayana (Director). Past directors included Vasanth Shantha Prashanth, Satyanarayana Thallam, Thallam Satyanarayana. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Anand Towers, Municipal No.4 Rajaram Mohan Roy Road, Sampangiramanaga, R, Bangalore, Karnataka, 560027.
U85110KA2011PTC057624
057624
15 March 2011
₹0.20 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Oncostem Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manjiri Manohar Bakre | Director | 17 Jun 2011 | Current |
| Thallam Satyanarayana | Director | 06 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Apr 2022 | Past |
| Pramod Abcsdd | Additional Director | - | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 17 Jun 2011 | Past |
| Pramod Abcsdd | Director | 23 May 2020 | Past |
| Pramod Abcsdd | Nominee Director | 23 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oncostem Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 43.66% decrease. The company also saw a substantial fall in profitability, with a 2016.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Oncostem Diagnostics had a promoter holding of 97.96% and a public holding of 2.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Oncostem Diagnostics has a workforce of 17 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oncostem Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncostem Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Oncostem Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Oncostem Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
The activity Thallam Satyanarayana was appointed as a Director was appointed as a Director on 06 Apr 2022 & has been associated with this company since 3 years 7 months . was completed.
Progress on Manjiri Manohar Bakre was appointed as a Director was appointed as a Director on 17 Jun 2011 & has been associated with this company since 14 years 5 months . was documented.
Progress on Oncostem Diagnostics Private Limited was registered on 15 Mar 2011 with Roc Bangalore & aged 14 years 8 months as per MCA records. was documented.
Oncology-focused startup OncoStem Diagnostics has secured $6 million (about Rs.38.5 crore) in a Sequoia India-led funding round that saw participation from existing investor Artiman Ventures..
The CIN of Oncostem Diagnostics Private Limited is U85110KA2011PTC057624.
Oncostem Diagnostics Private Limited is headquartered at Anand Towers, Municipal No.4 Rajaram Mohan Roy Road, Sampangiramanaga, R, Bangalore, Karnataka, 560027.
Oncostem Diagnostics Private Limited was incorporated on 15 March 2011.
The current directors of Oncostem Diagnostics Private Limited are
The primary industry of Oncostem Diagnostics Private Limited is Professional, Scientific And Technical.
Oncostem Diagnostics Private Limited is unlisted.
The authorized capital of Oncostem Diagnostics Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
The compliance status of Oncostem Diagnostics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX